Endocare

Endocare is a medical technology company that specializes in the development and commercialization of minimally invasive cryoablation systems for the treatment of various cancers. The company's flagship technology, the Cryocare System, uses extreme cold to precisely target and destroy malignant and benign tumors in organs such as the prostate, kidney, lung, and liver. By utilizing image-guided probes, Endocare's solutions provide a less invasive alternative to traditional surgical resection, often resulting in reduced patient recovery times. Originally an independent entity, the company's assets were acquired by Varian Medical Systems (now a Siemens Healthineers company) to expand their interventional oncology portfolio. Today, Endocare continues to lead in the cryotherapy space, offering a range of specialized probes and consoles for clinical use.